I attended the meeting as well as was seated near
Post# of 30027
Posted On: 09/23/2014 12:32:14 AM
I attended the meeting as well as was seated near barcode who did an excellent job in summarizing the meeting. A couple of things that were brought up:
A question regarding MANF IP expiration period of 7 years to which Dr. Rubinfeld mentioned that that would start the moment it was on the market. JC mentioned about a 12 year period.
In regards to the ratio of published papers of GDNF to MANF being 10 to 1. Dr. Lowe mentioned that it was sometimes a good thing to not have as many papers as it provide insights to competitors, but eventually MANF would catch up in the number of publications as more data results are available.
Barcode, if I have misstated in any way these comments please correct me.
I thought the meeting went very well and was surprised to see Dr. Rubinfeld in attendance
A question regarding MANF IP expiration period of 7 years to which Dr. Rubinfeld mentioned that that would start the moment it was on the market. JC mentioned about a 12 year period.
In regards to the ratio of published papers of GDNF to MANF being 10 to 1. Dr. Lowe mentioned that it was sometimes a good thing to not have as many papers as it provide insights to competitors, but eventually MANF would catch up in the number of publications as more data results are available.
Barcode, if I have misstated in any way these comments please correct me.
I thought the meeting went very well and was surprised to see Dr. Rubinfeld in attendance
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼